https://www.pharmacytimes.com/view/darovasertib-plus-crizotinib-shows-striking-efficacy-in-hla-a2-negative-metastatic-uveal-melanoma-optimum-02-results-show2026-06-03T20:55:00Z2026-06-03T20:55:00Z https://www.pharmacytimes.com/view/camizestrant-plus-cdk4-6-inhibitor-demonstrates-sustained-benefit-beyond-first-progression-in-esr1-mutated-breast-cancer2026-06-03T19:57:00Z2026-06-03T19:57:00Z https://www.pharmacytimes.com/view/fda-grants-priority-review-to-bezuclastinib-plus-sunitinib-for-patients-with-advanced-gist2026-06-03T19:32:55.822Z2026-06-03T19:32:55.822Z https://www.pharmacytimes.com/view/apnimed-submits-nda-for-ad109-following-positive-phase-3-results-in-obstructive-sleep-apnea2026-06-03T19:17:53.506Z2026-06-03T19:17:53.506Z https://www.pharmacytimes.com/view/real-world-data-reveals-opportunities-to-improve-her2-low-metastatic-breast-cancer-care2026-06-03T17:57:00Z2026-06-03T17:57:00Z https://www.pharmacytimes.com/view/early-ivig-use-associated-with-reduced-infections-and-improved-survival-in-patients-receiving-talquetamab-for-multiple-myeloma2026-06-03T17:03:37.844Z2026-06-03T17:03:37.844Z https://www.pharmacytimes.com/view/insights-into-a-multigenerational-pharmacy-residency-program2026-06-03T16:00:26.181Z2026-06-03T16:00:26.181Z https://www.pharmacytimes.com/view/what-pharmacists-need-to-know-about-retatrutide-s-triumph-1-phase-3-results2026-06-03T13:45:00Z2026-06-03T13:45:00Z https://www.pharmacytimes.com/view/first-in-human-in-vivo-car-t-therapy-shows-encouraging-activity-in-relapsed-refractory-multiple-myeloma2026-06-03T13:35:57.001Z2026-06-03T13:35:57.001Z https://www.pharmacytimes.com/view/fda-approves-ensitrelvir-for-post-exposure-prophylaxis-of-covid-19-in-adolescents-and-adults2026-06-02T19:29:12.426Z2026-06-02T19:29:12.426Z https://www.pharmacytimes.com/view/gire-combination-shows-pfs-benefit-in-first-line-metastatic-breast-cancer-earning-fda-priority-review2026-06-02T19:14:00Z2026-06-02T19:14:00Z https://www.pharmacytimes.com/view/why-sg-plus-pembrolizumab-s-best-results-may-come-after-first-progression2026-06-02T19:02:00Z2026-06-02T19:02:00Z https://www.pharmacytimes.com/view/exploring-pembrolizumab-plus-olaparib-in-brca-mutated-metastatic-pancreatic-cancer2026-06-02T18:34:00Z2026-06-02T18:34:00Z https://www.pharmacytimes.com/view/how-medication-stigma-and-bias-can-impact-patient-recovery2026-06-02T15:48:27.734Z2026-06-02T15:48:27.734Z https://www.pharmacytimes.com/view/daratumumab-plus-vrd-continues-to-demonstrate-durable-benefits-in-transplant-ineligible-newly-diagnosed-multiple-myeloma2026-06-02T15:35:02.592Z2026-06-02T15:35:02.592Z https://www.pharmacytimes.com/view/why-some-patients-do-not-respond-to-glp-1-therapies2026-06-02T15:00:17.443Z2026-06-02T15:00:17.443Z https://www.pharmacytimes.com/view/upcoming-ncpa-events-for-pharmacy-teams-june-and-july-20262026-06-02T14:41:30.286Z2026-06-02T14:41:30.286Z https://www.pharmacytimes.com/view/gene-writer-enables-stable-in-vivo-car-t-cell-engineering-through-rna-delivery2026-06-02T14:00:00Z2026-06-02T14:00:00Z https://www.pharmacytimes.com/view/why-patients-struggle-to-access-mental-health-and-addiction-treatment-medications2026-06-02T13:22:44.409Z2026-06-02T13:22:44.409Z https://www.pharmacytimes.com/view/sunmo-bispecifics-and-a-new-standard-for-relapsed-refractory-large-b-cell-lymphoma2026-06-01T23:10:00Z2026-06-01T23:10:00Z https://www.pharmacytimes.com/view/beyond-the-prescription-how-pharmacists-address-social-barriers-to-diabetes-care2026-06-01T19:24:50.441Z2026-06-01T19:24:50.441Z https://www.pharmacytimes.com/view/epro-based-monitoring-improves-early-symptom-management-in-patients-with-cancer2026-06-01T18:58:00Z2026-06-01T18:58:00Z https://www.pharmacytimes.com/view/could-glp-1-medications-influence-breast-cancer-survivorship-researchers-discuss-emerging-data2026-06-01T18:30:00Z2026-06-01T18:30:00Z https://www.pharmacytimes.com/view/daraxonrasib-changing-the-standard-of-care-in-second-line-metastatic-pancreatic-cancer2026-06-01T18:21:00Z2026-06-01T18:21:00Z https://www.pharmacytimes.com/view/encorafenib-plus-cetuximab-folfiri-demonstrates-significant-pfs-benefit-in-braf-v600e-mutant-metastatic-colorectal-cancer2026-06-01T18:00:00Z2026-06-01T18:00:00Z https://www.pharmacytimes.com/view/paneth-cells-and-ilc3s-drive-context-dependent-gi-regeneration-following-bmt2026-06-01T17:00:03.544Z2026-06-01T17:00:03.544Z https://www.pharmacytimes.com/view/glp-1-receptor-agonists-may-reduce-mortality-in-patients-with-cancer2026-06-01T16:57:00Z2026-06-01T16:57:00Z https://www.pharmacytimes.com/view/experts-weigh-in-on-finerenone-s-priority-review-for-ckd-in-type-1-diabetes2026-06-01T16:00:00Z2026-06-01T16:00:00Z https://www.pharmacytimes.com/view/how-health-care-stigma-affects-treatment-engagement-and-retention2026-06-01T15:16:58.849Z2026-06-01T15:16:58.849Z https://www.pharmacytimes.com/view/relief-of-acute-low-back-pain-with-naproxen-sodium2026-06-01T14:35:38.909Z2026-06-01T14:35:38.909Z https://www.pharmacytimes.com/view/debunking-common-myths-about-psychiatric-medications-in-congregate-care2026-06-01T14:28:21.195Z2026-06-01T14:28:21.195Z https://www.pharmacytimes.com/view/sarc041-and-abemaciclib-deliver-a-long-awaited-answer-in-dedifferentiated-liposarcoma2026-06-01T02:28:00Z2026-06-01T02:28:00Z https://www.pharmacytimes.com/view/proteus-trial-results-support-apalutamide-plus-adt-as-new-standard-of-care-in-high-risk-localized-prostate-cancer2026-06-01T01:26:00Z2026-06-01T01:26:00Z https://www.pharmacytimes.com/view/sarc041-and-the-future-of-dedifferentiated-liposarcoma-treatment2026-05-31T18:57:00Z2026-05-31T18:57:00Z https://www.pharmacytimes.com/view/the-future-of-localized-prostate-cancer-treatment-mary-ellen-taplin-md-and-the-proteus-trial2026-05-31T18:06:00Z2026-05-31T18:06:00Z https://www.pharmacytimes.com/view/adding-a-bcl-2-inhibitor-to-btk-inhibitor-therapy-can-lisaftoclax-close-the-gap-for-high-risk-cll-2026-05-30T23:13:00Z2026-05-30T23:13:00Z https://www.pharmacytimes.com/view/7-years-and-still-going-lorlatinib-continues-to-rewrite-the-rules-in-alk-nsclc2026-05-30T17:05:00Z2026-05-30T17:05:00Z https://www.pharmacytimes.com/view/app-led-benign-hematology-consults-reduce-wait-times-and-expand-access-in-community-oncology2026-05-30T15:24:30.966Z2026-05-30T15:24:30.966Z https://www.pharmacytimes.com/view/dreamm-9-optimizing-belantamab-mafodotin-dosing-in-transplant-ineligible-newly-diagnosed-multiple-myeloma2026-05-30T13:59:00Z2026-05-30T13:59:00Z https://www.pharmacytimes.com/view/enfortumab-vedotin-plus-pembrolizumab-sustains-survival-advantage-at-3-5-years-2026-05-30T03:25:00Z2026-05-30T03:25:00Z https://www.pharmacytimes.com/view/phase-3-data-back-a-new-perioperative-standard-for-cisplatin-eligible-muscle-invasive-bladder-cancer2026-05-29T20:20:00Z2026-05-29T20:20:00Z https://www.pharmacytimes.com/view/glofitamab-monotherapy-demonstrates-durable-responses-in-relapsed-refractory-mantle-cell-lymphoma2026-05-29T19:57:00Z2026-05-29T19:57:00Z https://www.pharmacytimes.com/view/nearly-3-5-years-of-survival-what-chrysalis-2-means-for-atypical-egfr-mutated-nsclc2026-05-29T19:15:00Z2026-05-29T19:15:00Z https://www.pharmacytimes.com/view/glp-1-therapies-may-shape-future-breast-cancer-survivorship-and-metabolic-care-strategies2026-05-29T18:30:00Z2026-05-29T18:30:00Z https://www.pharmacytimes.com/view/cellular-immune-reconstitution-varies-across-gvhd-prophylaxis-strategies-in-hsct2026-05-29T18:00:27.473Z2026-05-29T18:00:27.473Z https://www.pharmacytimes.com/view/fda-approves-afrezza-insulin-inhalation-powder-for-children-adolescents-with-type-1-and-type-2-diabetes2026-05-29T17:06:33.856Z2026-05-29T17:06:33.856Z https://www.pharmacytimes.com/view/asco-kickoff-cancer-vaccines-cell-therapies-and-ai-driven-precision-oncology-signal-the-next-era-of-immunotherapy2026-05-29T16:45:00Z2026-05-29T16:45:00Z https://www.pharmacytimes.com/view/why-approved-medications-are-not-started-on-time-the-pbm-authorization-delay-nobody-talks-about2026-05-29T14:41:00Z2026-05-29T14:41:00Z https://www.pharmacytimes.com/view/subgroup-analysis-reveals-ofatumumab-s-potent-efficacy-in-highly-active-relapsing-ms2026-05-29T14:16:54.795Z2026-05-29T14:16:54.795Z https://www.pharmacytimes.com/view/scientists-identify-key-causal-risks-for-nmosd2026-05-29T13:57:17.861Z2026-05-29T13:57:17.861Z https://www.pharmacytimes.com/view/fenebrutinib-demonstrates-superior-efficacy-in-reducing-relapses-and-brain-lesions-in-pivotal-phase-3-ms-trials2026-05-29T13:24:35.612Z2026-05-29T13:24:35.612Z https://www.pharmacytimes.com/view/new-ublituximab-data-highlight-rapid-patient-gains-and-a-path-toward-single-day-treatment-initiation2026-05-28T20:34:00Z2026-05-28T20:34:00Z https://www.pharmacytimes.com/view/rethinking-long-term-ms-therapy-de-escalation-biomarkers-and-the-future-of-care2026-05-28T20:18:00Z2026-05-28T20:18:00Z https://www.pharmacytimes.com/view/aging-study-reveals-cladribine-tablets-as-a-potent-option-for-older-patients-with-ms2026-05-28T20:00:00Z2026-05-28T20:00:00Z https://www.pharmacytimes.com/view/rethinking-escalation-in-relapsing-ms2026-05-28T19:31:45.782Z2026-05-28T19:31:45.782Z https://www.pharmacytimes.com/view/social-risk-factors-tied-to-advanced-ckm-syndrome-vary-by-race-ethnicity-and-sex2026-05-28T19:30:00Z2026-05-28T19:30:00Z https://www.pharmacytimes.com/view/long-term-efficacy-and-safety-frexalimab-shows-sustained-success-in-3-year-phase-2-ms-data2026-05-28T19:30:00Z2026-05-28T19:30:00Z https://www.pharmacytimes.com/view/proteomic-liquid-biopsies-could-expand-early-breast-cancer-detection-and-precision-oncology-strategies2026-05-28T18:54:37.543Z2026-05-28T18:54:37.543Z https://www.pharmacytimes.com/view/fda-approves-durvalumab-plus-bcg-for-high-risk-non-muscle-invasive-bladder-cancer2026-05-28T17:24:00Z2026-05-28T17:24:00Z https://www.pharmacytimes.com/view/optimizing-biomarker-driven-treatment-and-immune-checkpoint-inhibitor-counseling-in-endometrial-cancer2026-05-28T16:00:00Z2026-05-28T16:00:00Z https://www.pharmacytimes.com/view/navigating-the-growing-impact-of-alternative-funding-programs-copay-accumulators-and-maximizers-on-specialty-medication-access2026-05-28T14:00:00Z2026-05-28T14:00:00Z https://www.pharmacytimes.com/view/the-future-of-glp-1-therapies-hype-evidence-and-the-expanding-role-of-pharmacists2026-05-28T13:59:07.988Z2026-05-28T13:59:07.988Z https://www.pharmacytimes.com/view/the-pharmacist-s-role-in-ms-supplement-safety2026-05-28T13:17:50.978Z2026-05-28T13:17:50.978Z https://www.pharmacytimes.com/view/expanding-the-role-of-pharmacists-in-non-statin-ldl-c-therapy-utilization2026-05-28T12:05:00Z2026-05-28T12:05:00Z https://www.pharmacytimes.com/view/facilitating-access-to-non-statin-ldl-c-lowering-therapies2026-05-28T12:00:00Z2026-05-28T12:00:00Z https://www.pharmacytimes.com/view/navigating-the-ms-therapy-explosion-strategies-for-proactive-initiation-and-smart-treatment-switching2026-05-27T20:01:13.035Z2026-05-27T20:01:13.035Z https://www.pharmacytimes.com/view/ms-supplements-what-works-and-what-doesn-t2026-05-27T19:09:15.978Z2026-05-27T19:09:15.978Z https://www.pharmacytimes.com/view/positive-phase-3-results-support-simplified-ublituximab-xiiy-dosing-for-relapsing-ms2026-05-27T18:33:22.988Z2026-05-27T18:33:22.988Z https://www.pharmacytimes.com/view/experts-discuss-the-potential-role-of-glp-1-receptor-agonists-in-breast-cancer-outcomes-and-survivorship-care2026-05-27T18:16:44.968Z2026-05-27T18:16:44.968Z https://www.pharmacytimes.com/view/understanding-dermatologic-care-in-skin-of-color-limitations-in-education-and-research-clinical-considerations-and-patient-counseling2026-05-27T17:52:22.310Z2026-05-27T17:52:22.310Z https://www.pharmacytimes.com/view/ugn-103-shows-promise-in-recurrent-low-grade-bladder-cancer2026-05-27T17:26:00Z2026-05-27T17:26:00Z https://www.pharmacytimes.com/view/the-pharmacist-s-role-in-managing-high-risk-ms-patients2026-05-27T17:21:14.904Z2026-05-27T17:21:14.904Z https://www.pharmacytimes.com/view/managing-high-risk-ms-patients-safety-treatment-and-emerging-strategies2026-05-27T16:56:33.535Z2026-05-27T16:56:33.535Z https://www.pharmacytimes.com/view/pirtobrutinib-efficacious-tolerable-in-patients-with-treatment-na-ve-cll-sll2026-05-27T16:45:00Z2026-05-27T16:45:00Z https://www.pharmacytimes.com/view/biomarker-testing-and-immune-checkpoint-inhibitor-counseling-shape-endometrial-cancer-care2026-05-27T16:00:00Z2026-05-27T16:00:00Z https://www.pharmacytimes.com/view/recent-covid-19-vaccination-associated-with-nearly-half-the-risk-of-household-transmission2026-05-27T15:34:03.867Z2026-05-27T15:34:03.867Z https://www.pharmacytimes.com/view/centers-for-medicare-medicaid-services-questions-with-usp-s-tim-casey-senior-director-of-government-affairs2026-05-27T15:33:00Z2026-05-27T15:33:00Z https://www.pharmacytimes.com/view/axs26-what-must-change-in-cgt-reimbursement-before-volume-increases2026-05-27T14:30:00Z2026-05-27T14:30:00Z https://www.pharmacytimes.com/view/what-s-making-headlines-in-cardiovascular-care-a-pharmacist-s-breakdown-of-the-latest-breakthroughs2026-05-27T13:57:44.589Z2026-05-27T13:57:44.589Z https://www.pharmacytimes.com/view/axs26-how-payers-providers-and-employers-view-cell-and-gene-therapy-access-and-where-they-agree2026-05-26T20:53:20.127Z2026-05-26T20:53:20.127Z https://www.pharmacytimes.com/view/from-rybelsus-to-the-wegovy-pill-what-pharmacists-need-to-know-about-the-next-generation-of-oral-semaglutide2026-05-26T20:00:34.747Z2026-05-26T20:00:34.747Z https://www.pharmacytimes.com/view/specialty-pharmacy-explained-growth-pricing-and-industry-economics2026-05-26T18:00:45.372Z2026-05-26T18:00:45.372Z https://www.pharmacytimes.com/view/ebola-bundibugyo-virus-outbreak-in-the-drc-and-uganda-what-pharmacists-need-to-know2026-05-26T15:43:00.598Z2026-05-26T15:43:00.598Z https://www.pharmacytimes.com/view/immune-checkpoint-inhibitors-redefine-frontline-treatment-and-toxicity-management-in-advanced-endometrial-cancer2026-05-26T15:42:44.507Z2026-05-26T15:42:44.507Z https://www.pharmacytimes.com/view/glp-1s-were-only-the-beginning-the-growing-role-of-pharmacists-in-peptide-medicine2026-05-26T15:27:33.758Z2026-05-26T15:27:33.758Z https://www.pharmacytimes.com/view/hepatitis-awareness-month-the-role-of-pharmacists-in-combating-misinformation-and-vaccine-hesitancy2026-05-26T14:37:27.333Z2026-05-26T14:37:27.333Z https://www.pharmacytimes.com/view/fda-approves-bulevirtide-gmod-as-first-ever-treatment-for-chronic-hepatitis-delta-virus-infection2026-05-26T13:34:39.217Z2026-05-26T13:34:39.217Z https://www.pharmacytimes.com/view/-if-i-had-my-wish-pharmacist-outlines-how-to-transform-schizophrenia-treatment2026-05-26T13:24:00Z2026-05-26T13:24:00Z https://www.pharmacytimes.com/view/from-glp-1s-to-vaccines-apha-2026-showcased-the-modern-clinical-pharmacist2026-05-26T13:05:42.883Z2026-05-26T13:05:42.883Z https://www.pharmacytimes.com/view/the-weekly-dose-trumprx-expansion-hepatitis-b-vaccination-gaps-and-new-fda-approvals2026-05-25T21:00:00Z2026-05-25T21:00:00Z https://www.pharmacytimes.com/view/expanding-the-field-who-qualifies-for-cgm-aid-and-continuous-ketone-monitoring-2026-05-25T19:45:00Z2026-05-25T19:45:00Z https://www.pharmacytimes.com/view/depression-common-in-asthma-but-moderate-to-severe-disease-worsens-outcomes2026-05-25T17:00:00Z2026-05-25T17:00:00Z https://www.pharmacytimes.com/view/fda-grants-priority-review-to-finerenone-for-chronic-kidney-disease-in-adults-with-type-1-diabetes2026-05-25T15:30:00Z2026-05-25T15:30:00Z https://www.pharmacytimes.com/view/managing-toxicities-and-shaping-the-next-5-years-of-endometrial-cancer-care2026-05-25T12:05:00Z2026-05-25T12:05:00Z https://www.pharmacytimes.com/view/the-science-of-selection-pharmacist-initiatives-in-endometrial-cancer-care2026-05-25T12:00:00Z2026-05-25T12:00:00Z https://www.pharmacytimes.com/view/world-schizophrenia-day-one-pharmacist-s-vision-for-safer-schizophrenia-care2026-05-24T13:24:00Z2026-05-24T13:24:00Z https://www.pharmacytimes.com/view/the-cgm-data-point-pharmacists-should-always-check-first2026-05-23T14:58:00Z2026-05-23T14:58:00Z https://www.pharmacytimes.com/view/early-oral-antiviral-use-associated-with-lower-risk-of-post-covid-19-condition-study-finds2026-05-22T18:00:19.315Z2026-05-22T18:00:19.315Z https://www.pharmacytimes.com/view/q-a-strengthening-oncology-real-world-data-quality-through-clinically-relevant-edit-checks2026-05-22T17:31:43.237Z2026-05-22T17:31:43.237Z https://www.pharmacytimes.com/view/tpa-ncpa-applaud-tennessee-law-banning-pbms-from-owning-pharmacies2026-05-22T17:05:33.309Z2026-05-22T17:05:33.309Z